OUR RESEARCH

The blood-brain barrier is the interface between blood and brain that controls what goes in and comes out of the brain.

Anatomically, the blood-brain barrier is made of endothelial cells forming a complex vascular network that supplies the brain with oxygen and nutrients, and disposes of carbon dioxide and wastes.

Recent studies show that the blood-brain barrier is affected by brain disorders and itself plays a role in causing brain disease. Therefore, understanding blood-brain barrier function is critical for devising new therapeutic strategies to enhance brain drug delivery, improve brain protection, and treat brain disorders.
Currently, we study the role of the blood-brain barrier in three diseases:

RECENT PUBLICATIONS

Velmurugan GV, Vekaria HJ, Hartz AMS, Bauer B, Hubbard WB

2024 21:81, https://doi.org/10.1186/s12987-024-00579-9

Neurovascular deficits and blood-brain barrier (BBB) dysfunction are major hallmarks of brain traumaand neurodegenerative diseases. Oxidative stress is a prominent contributor to neurovascular unit (NVU) dysfunction and can propagate BBB disruption. Oxidative damage results in

Rodgers LT, Villano JL, Hartz AMS, Bauer B

2024, 16, 2638. https://doi.org/10.3390/cancers16152638

Rodgers LT, Schulz Pauly JA, Maloney BJ, Hartz AMS, Bauer B

2024, 16, 1997. https://doi.org/10.3390/ cancers16111997

Glioblastoma (GBM) is the most aggressive brain cancer. To model GBM in research,orthotopic brain tumor models, including syngeneic models like GL261 and genetically engineeredmouse models like TRP, are used. In longitudinal studies, tumor growth and

CONTACT US

University of Kentucky
760 Press Ave, 124 HKRB
Lexington, KY 40536-0679
USA
bauerhartzlab@uky.edu